Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Unaudited Consolidated Statements of Cash Flows

v3.19.3
Condensed Unaudited Consolidated Statements of Cash Flows - CAD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Operating activities        
Net loss for the period $ (5,333,621) $ (2,890,320) $ (22,682,124) $ (7,910,509)
Adjustments for:        
Amortization 268,932 68,917 798,912 197,332
Stock-based compensation expense 1,597,779 644,228 4,148,806 2,528,643
Share-based payment expense (recovery) (39,426) 312,960 206,516 935,837
Interest on lease liability 36,488   104,673  
Changes in fair value of derivative liability (2,107,474) (1,919,072) 3,412,917 (4,945,126)
Deferred income tax recovery (6,894)   (56,069)  
Changes in non-cash working capital items:        
Receivables 1,318,042 229,370 803,558 (154,668)
Prepaid expenses 851,321 (312,906) (3,959,468) (155,576)
Inventory 198,103 (732,551) (444,079) (774,166)
Trade payables and accrued liabilities 391,756 (365,858) (93,305) 76,532
Customer deposits and construction contract liabilities 41,522 (1,862) 97,256 (38,159)
Net cash flows used in operating activities (2,783,472) (4,967,094) (17,662,407) (10,239,860)
Investing activities        
Restricted cash (589) 1,213 1,042 (107,782)
Expenditures on plant and equipment (2,147,066) (1,030,641) (3,415,881) (3,884,515)
Expenditures on intangible assets (13,050)   (5,008)  
Net cash flows used in investing activities (2,160,705) (1,029,428) (3,419,847) (3,992,297)
Financing activities        
Repayment of bank loan       (123,637)
Repayment of shareholder loan (1,038) (1,038) (3,115) (3,115)
Repayment of promissory note       (1,500,000)
Repayment of leases (187,950)   (555,782)  
Proceeds on issuance of common shares - net of issue costs (15,699) 13,900,448 14,699,097 19,386,116
Proceeds from issuance of common shares for options exercised     35,008  
Proceeds from issuance of common shares for warrants exercised     4,195,286  
Net cash flows from financing activities (204,687) 13,899,410 18,370,494 17,759,364
Increase (decrease) in cash and cash equivalents (5,148,864) 7,902,888 (2,771,760) 3,527,207
Effect of exchange rate changes on cash and cash equivalents (14,257) (24) 10,330 (24)
Cash and cash equivalents, beginning 21,388,624 4,235,315 18,926,933 8,610,996
Cash and cash equivalents, ending 16,225,503 12,138,179 16,225,503 12,138,179
Supplemental schedule of non-cash investing and financing activities        
Purchase of PP&E in accounts payable 142,658 566,122 142,658 566,122
Right-of-use assets obtained in exchange for lease liability     2,106,966  
Shares issued for services $ (39,426) $ 312,960 $ 206,516 $ 935,837